User menu

Treatment of acute lymphoblastic leukemia in the elderly: An evaluation of interferon alpha given as a single agent after complete remission

Bibliographic reference Delannoy, A. ; Cazin, B. ; Thomas, X. ; Bouabdallah, R. ; Boiron, J.M. ; et. al. Treatment of acute lymphoblastic leukemia in the elderly: An evaluation of interferon alpha given as a single agent after complete remission. In: Leukemia and Lymphoma, Vol. 43, no. 1, p. 75-81 (2002)
Permanent URL
  1. The Southwest Oncology Group, Blood, 73, 57 (1989)
  2. Delannoy A., Ferrant A., Bosly A., Chatelain C., Doyen C., Martiat P., Michaux J. L., Sokal G., Acute lymphoblastic leukemia in the elderly, 10.1111/j.1600-0609.1990.tb00424.x
  3. Taylor P.R.A., Blood, 80, 1813 (1992)
  4. Virgilio J. F., Moscinski L. C., Ballester O. F., Corrado C., Guida C., Balducci L., Saba H., Acute lymphocytic leukemia (all) in elderly patients, 10.1002/hon.2900110302
  5. Späth-Schwalbe E., Heil G., Heimpel H., Acute lymphoblastic leukemia in patients over 59 years of age : Experience in a single center over a 10-year period, 10.1007/bf01696557
  6. Kantarjian Hagop M., O'Brien Susan, Smith Terry, Estey Elihu H., Berran Miloslav, Preti Alejandro, Pierce Sherry, Keating Michael J., Acute lymphocytic leukaemia in the elderly: characteristics and outsome with the vincristine-adriamycin-dexamethasone (VAD) regimen, 10.1111/j.1365-2141.1994.tb04982.x
  7. Ferrari A., Leukemia, 9, 1643 (1995)
  8. Bassan Renato, Bona Eros Di, Lerede Teresa, Pogliani Enrico, Rossi Giuseppe, D'emilio Anna, Buelli Maurizio, Rambaldi Alessandro, Viero Piera, Rodeghiero Francesco, Barbui Tiziano, Age-Adapted Moderate-Dose Induction and Flexible Outpatient Postremission Therapy for Elderly Patients with Acute Lymphoblastic Leukemia, 10.3109/10428199609051761
  9. LEGRAND OLLIVIER, MARIE JEAN-PIERRE, MARJANOVIC ZORA, CADIOU MONIQUE, BLANC CLAUDE, RAMOND SYLVIE, VIGUIE FRANCK, PERROT JEAN-YVES, ZITTOUN ROBERT, Prognostic factors in elderly acute lymphoblastic leukaemia, 10.1046/j.1365-2141.1997.952909.x
  10. Delannoy A, Sebban C, Cony-Makhoul P, Cazin B, Cordonnier C, Bouabdallah R, Cahn J Y, Dreyfus F, Sadoun A, Vernant J P, Gay C, Broustet A, Michaux J L, Fière D, Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients, 10.1038/sj.leu.2400780
  11. Kantarjian H.M., Journal of Clinical Oncology, 18, 547 (2000)
  12. For the Gimema Group, Annals of Hematology, 70, 41 (1995)
  13. Mele L., The Hematology Journal, 1, 113 (2000)
  14. Larson R.A., Blood, 92, 1556 (1998)
  15. Nagura E., Nippon Ronen Igakkai Zasshi, 36, 52 (1999)
  16. Goekbuget N., Blood, 96, 718a (2000)
  17. EINHORN S, Prolonged remission induced by interferon-$alpha; in a patient with refractory T-cell ALL, 10.1016/0140-6736(90)90911-n
  18. Ochs J., Journal of Clinical Oncology, 9, 777 (1991)
  19. Makhonova L.A., Gematolgiia i Transfuziologiia, 34, 33 (1989)
  20. Opat B., Neoplasma, 36, 489 (1989)
  21. Lauer Stephen J., Ochs Judith, Pollock Brad H., Buchanan George R., Recombinant alpha-2B interferon treatment for childhood t-lymphoblastic disease in relapse. A pediatric oncology group phase II study, 10.1002/1097-0142(19940701)74:1<197::aid-cncr2820740131>;2-9
  22. Bene M.C., Leukemia, 9, 1783 (1995)
  23. Groupe Français, Blood, 87, 3135 (1996)
  24. Fière D., Journal of Clinical Oncology, 11, 1990 (1993)